Oncolytics Biotech Inc (ONC.TO)
1.59
-0.10
(-5.92%)
CAD |
TSX |
May 10, 16:00
Oncolytics Biotech Max Drawdown (5Y): 96.05% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 96.05% |
March 31, 2024 | 96.05% |
February 29, 2024 | 96.05% |
January 31, 2024 | 96.05% |
December 31, 2023 | 96.05% |
November 30, 2023 | 96.05% |
October 31, 2023 | 96.05% |
September 30, 2023 | 96.05% |
August 31, 2023 | 96.05% |
July 31, 2023 | 96.05% |
June 30, 2023 | 96.05% |
May 31, 2023 | 96.05% |
April 30, 2023 | 96.05% |
March 31, 2023 | 96.05% |
February 28, 2023 | 96.05% |
January 31, 2023 | 96.05% |
December 31, 2022 | 96.05% |
November 30, 2022 | 96.05% |
October 31, 2022 | 96.05% |
September 30, 2022 | 96.05% |
August 31, 2022 | 96.05% |
July 31, 2022 | 96.05% |
June 30, 2022 | 96.05% |
May 31, 2022 | 96.05% |
April 30, 2022 | 96.05% |
Date | Value |
---|---|
March 31, 2022 | 96.05% |
February 28, 2022 | 96.05% |
January 31, 2022 | 96.05% |
December 31, 2021 | 96.05% |
November 30, 2021 | 96.05% |
October 31, 2021 | 96.05% |
September 30, 2021 | 96.09% |
August 31, 2021 | 96.24% |
July 31, 2021 | 96.24% |
June 30, 2021 | 96.24% |
May 31, 2021 | 96.24% |
April 30, 2021 | 96.24% |
March 31, 2021 | 96.24% |
February 28, 2021 | 96.24% |
January 31, 2021 | 96.24% |
December 31, 2020 | 96.24% |
November 30, 2020 | 96.24% |
October 31, 2020 | 96.24% |
September 30, 2020 | 96.24% |
August 31, 2020 | 96.24% |
July 31, 2020 | 96.24% |
June 30, 2020 | 96.24% |
May 31, 2020 | 96.24% |
April 30, 2020 | 96.24% |
March 31, 2020 | 96.24% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
96.05%
Minimum
Oct 2021
96.24%
Maximum
May 2019
96.14%
Average
96.05%
Median
Oct 2021
Max Drawdown (5Y) Benchmarks
Biocure Technology Inc | 99.70% |
Core One Labs Inc | 99.78% |
Nova Mentis Life Science Corp | 99.28% |
Nanosphere Health Sciences Inc | 99.95% |
Lobe Sciences Ltd | -- |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -21.38 |
Beta (5Y) | 1.341 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 133.1% |
Historical Sharpe Ratio (5Y) | -0.0904 |
Historical Sortino (5Y) | -0.2882 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 31.76% |